Clinical Research Directory
Browse clinical research sites, groups, and studies.
AKG and Brain Health in Aging
Sponsor: University of Oklahoma
Summary
This proposal will test the hypothesis that AKG supplementation will improve NGVC responses and cognitive performance in older adults. We will also test the hypothesis that these effects are mediated by a decrease in age-related oxidative stress within NGVU cells.
Official title: Alpha-Ketoglutarate: A Novel Therapeutic Strategy to Improve Neurogliovascular Coupling and Cognitive Aging in Older Adults
Key Details
Gender
All
Age Range
55 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2027-02-01
Completion Date
2029-08-31
Last Updated
2026-10-06
Healthy Volunteers
Yes
Conditions
Interventions
Calcium AKG
Participants will be randomized to receive either oral Calcium AKG at a total daily dose of 1 g or an identically appearing placebo for 24 weeks.
Oral placebo capsules
identically appearing placebo capsule